Why Are Alzheimer’s Disease Clinical Trials So Challenging To Carry Out?
Alzheimer’s disease is one of the most difficult diseases to understand and develop new treatments for. Clinical trials for Alzheimer’s are expensive and lengthy and even when funding exists, it can be hard to find participants for them in time to optimize testing results. Also, because they have a traditionally high failure rate, they generate reticence, hesitation, and bias.
Why Are Alzheimer’s Disease Clinical Trials So Challenging To Carry Out? Read More »